Perrigo Company (PRGO)

103.00 +0.08 +0.08% May 25, 11:00PM Go Pro

View Full Chart PRGO Price Chart

Key Stats

Market Cap	9.610B
Revenue Growth	12.50%
Profit Margin	14.87%
Earnings Yield	3.84%
Dividend Yield	0.30%
Earnings Per Share TTM	3.95
PE Ratio	26.08
Price / Sales Ratio	3.155
52 Week High	108.60
52 Week Low	75.89
Beta	0.6386

View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More

Pro Value Score Go Pro
Pro Fundamental Score Go Pro
Pro Valuation from Historical Multiples Go Pro

Options

News

May 24	$TARO holders sign this online petition if u agree->http://stks.co/3yVp will be sent to BOD $TEVA $EIS $AISHX $PRGO $MYL $PFE by imhobutdydd
May 23	$PRGO Insider Sale: $1.6M of stock sold by Joseph Papa on May 21, 2012 http://stks.co/3xaX by MarketBrief
May 22	Perrigo (PRGO) Gets FDA Approval for Generic Gynazole 1 Street Insider
May 22	Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream Benzinga
May 18	Healthcare Business Recap: Dendreon Attack Continues, Pfizer Recall
May 18	Perrigo launches generic version of heartburn drug
May 18	Perrigo (PRGO) Gets Final FDA Approval for Generic Prevacid Caps (NVS) Street Insider
May 18	InPlay: Perrigo announces FDA final approval and launch of store brand OTC Lansoprazo...
May 18	Perrigo Announces FDA Final Approval and Launch of Store Brand OTC Lansoprazole 15mg ...
May 18	Cumberland Pharmaceuticals Sues Perrigo and InnoPharma
May 16	$PRGO http://stks.co/3reG shorted at 102.61. Right now still consolidating at the resistance. by hpymaggie
May 16	$TARO Mispriced -> http://stks.co/3rbz $TEVA $PRGO $VTUS $PFE $AMRN by imhobutdydd
May 14	$TARO A Tale of 2 Public companies -> http://stks.co/3oYE $TEVA $PRGO $VTUS $PFE $AMRN by imhobutdydd

Profile

Exchange: NASDAQGS Sector: Healthcare Industry: Drug Related Products

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products. The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The Company's primary markets and locations of manufacturing facilities are the United States, Israel, Mexico and the United Kingdom. The company's shares are traded on the NASDAQ and the Tel Aviv Stock Exchange; as a result of the merger with Agis Industries the company is a constituent of the TA-25 Index. The company was founded in 1887 and is headquartered in Allegan, Michigan.

View Performance

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Perrigo Company is up 21.89% over the last year vs S&P 500 Total Return up 2.03%, Health Care REIT up 12.14%, and Titanium Metals Corporation down 33.39%.

PRGO Total Returns
^SPXTR Total Returns
HCN Total Returns
TIE Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Pro Strategies Featuring PRGO

Did Perrigo Company make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

PRGO Charts

Other PRGO Resources

Recent Quotes

Symbol	Price	Chg	Chg %	Market Cap
PRGO	103.00	+0.08	+0.08%	9.610B
PRGN	0.58	+0.00	+0.83%	34.72M
PRFT	11.57	+0.10	+0.87%	361.79M
PRF	56.28	-0.01	-0.02%
PRE	72.31	+0.30	+0.42%	4.728B
PRCP	5.26	+0.03	+0.57%	44.18M
PPT	5.41	-0.04	-0.73%
POWL	34.81	-0.13	-0.37%	409.02M
POT	39.78	-0.42	-1.04%	34.16B
PNSN	0.2401	-0.06	-19.91%	6.718M

Create Watchlist from Stock Quotes